Cell line · CVCL_0455
NCI-H292
Cancer cell line, Homo sapiens. Lung mucoepidermoid carcinoma. 51 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H292. Cell lines, record CVCL_0455. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0455
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H292
- Accession
- CVCL_0455
- RRID
- RRID:CVCL_0455
- Synonyms
- H292, H-292, NCI-HUT-292, Hut292, NCIH292
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 32Y
- Category
- Cancer cell line
- Diseases
- Lung mucoepidermoid carcinoma (NCIt C45544)
- Derived from
- Lymph node (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers51
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The CLEC7A Y238∗ variant and susceptibility to pneumonia: a prospective population-based cohort study and mechanistic investigation. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of LIMK by Cofilin-1 peptidomimetics enhances actin depolymerization and reduces metastasis of non-small cell lung cancer. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ADCE-T02: A Next-generation Antibody-Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and Tolerability. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The p53 tumor suppressor modulates the expression of proteins that control natural killer cell activity. | Cell Commun Signal | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti-PD-1 Therapy. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DS-3939a: A TA-MUC1-Directed Antibody-Drug Conjugate with Broad Antitumor Activity. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 51
See all 51 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Hut292DM | CVCL_B409 | Cell lines | |
| Derived from it | NCI-H292-Luc | CVCL_D7FF | Cell lines | |
| Derived from it | Ubigene NCI-H292 EPCAM KO | CVCL_E0ZT | Cell lines |
Cell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1848 | ATCC | |
| BCRC | 60372 | BCRC | |
| BCRJ | 0187 | BCRJ | |
| CCTCC | GDC0211 | Cellosaurus | |
| CLS | 305040 | CLS | |
| ECACC | 91091815 | ECACC | |
| ICLC | HTL96009 | ICLC | |
| KCB | KCB 200822YJ | Cellosaurus | |
| KCLB | 21848 | Discontinued | Cellosaurus |
| Ubigene | YC-B006 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0455
GET https://conductscience.org/api/cell-lines/v1/CVCL_0455/papers?page=2